Binding of (MTR)2Zn2+ complex to chromatin: a comparison with (MTR)2Mg2+ complex

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Mithramycin (MTR) is an anticancer antibiotic that inhibits DNA replication and transcription by binding to GC-rich DNA sequences.
• Magnesium ions (Mg2+) are essential for MTR's DNA binding and transcription inhibition at physiological pH.
• Zinc ions (Zn2+) are crucial cofactors in enzymes and DNA-binding proteins, suggesting a potential role in MTR's mechanism.

Purpose of the Study:

• To characterize the complex formed between mithramycin and Zn2+.
• To investigate the DNA binding properties of the mithramycin-Zn2+ complex.
• To understand the effect of the mithramycin-Zn2+ complex on nucleosome structure and stability.

Main Methods:

• Spectroscopic methods were used to characterize the mithramycin-Zn2+ complex.
• DNA binding studies were performed using calf thymus DNA, rat liver chromatin, and nucleosome core particles.
• The effect of the complex on nucleosome stability was examined.

Main Results:

• Mithramycin forms a 2:1 complex with Zn2+ ((MTR)2Zn2+).
• The (MTR)2Zn2+ complex exhibits higher affinity for calf thymus DNA compared to the MTR-Mg2+ complex.
• Histone proteins hinder the binding of (MTR)2Zn2+ to nucleosomal DNA.
• The (MTR)2Zn2+ complex disassembles nucleosome core particles, releasing DNA.

Conclusions:

• The mithramycin-Zn2+ complex represents a distinct DNA-binding entity with potentially altered biological activity.
• Understanding the interaction of (MTR)2Zn2+ with DNA and chromatin provides insights into the in vivo mechanism of mithramycin.
• The nucleosome-disrupting property of the complex may contribute to mithramycin's anticancer effects.